Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing

View ORCID ProfileAlvin Kuo Jing Teo, Yukti Choudhury, View ORCID ProfileIain Beehuat Tan, Chae Yin Cher, Shi Hao Chew, Zi Yi Wan, View ORCID ProfileLionel Tim Ee Cheng, Lynette Lin Ean Oon, Min Han Tan, Kian Sing Chan, View ORCID ProfileLi Yang Hsu
doi: https://doi.org/10.1101/2020.08.13.20173807
Alvin Kuo Jing Teo
1Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alvin Kuo Jing Teo
Yukti Choudhury
2Lucence Diagnostics, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iain Beehuat Tan
3Department of Medical Oncology, National Cancer Centre, Singapore
4Duke-NUS Graduate Medical School, National University of Singapore
5Genome Institute of Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Iain Beehuat Tan
Chae Yin Cher
2Lucence Diagnostics, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shi Hao Chew
6Headquarters Army Medical Services, Singapore Armed Forces, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zi Yi Wan
2Lucence Diagnostics, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel Tim Ee Cheng
7Department of Diagnostic Radiology, Singapore General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lionel Tim Ee Cheng
Lynette Lin Ean Oon
8Department of Molecular Pathology, Singapore General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Han Tan
2Lucence Diagnostics, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kian Sing Chan
7Department of Diagnostic Radiology, Singapore General Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Yang Hsu
1Saw Swee Hock School of Public Health, National University of Singapore, National University Health System, Singapore
9Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Li Yang Hsu
  • For correspondence: mdchlv@nus.edu.sg
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Active cases of COVID-19 has primarily been diagnosed via RT-PCR of nasopharyngeal (NP) swabs. Saliva and self-administered nasal (SN) swabs can be collected safely without trained staff.

We aimed to test the sensitivity of “naso-oropharyngeal” saliva and SN swabs compared to NP swabs in a large cohort of migrant workers in Singapore.

Methods We recruited 200 male adult subjects: 45 with acute respiratory infection, 104 asymptomatic close contacts, and 51 confirmed COVID-19 cases. Each subject underwent NP swab, SN swab and saliva collection for RT-PCR testing at 1 to 3 timepoints. We additionally used a direct-from-sample amplicon-based next-generation sequencing (NGS) workflow to establish phylogeny.

Results Of 200 subjects, 91 and 46 completed second and third rounds of testing, respectively. Of 337 sets of tests, there were 150 (44.5%) positive NP swabs, 127 (37.7%) positive SN swabs, and 209 (62.0%) positive saliva.

Test concordance between different sample sites was good, with a kappa statistic of 0.616 for NP and SN swabs, and 0.537 for NP and saliva. In confirmed symptomatic COVID-19 subjects, the likelihood of a positive test from any sample fell beyond 14 days of symptom onset.

NGS was conducted on 18 SN and saliva samples, with phylogenetic analyses demonstrating lineages for all samples tested were Clade O (GISAID nomenclature) and lineage B.6 (PANGOLIN nomenclature).

Conclusion This study supports saliva as a sensitive and less intrusive sample for COVID-19 diagnosis and further delineates the role of oropharyngeal secretions in increasing the sensitivity of testing. However, SN swabs were inferior as an alternate sample type. Our study also provides evidence that a straightforward next-generation sequencing workflow can provide direct-from-sample phylogenetic analysis for public health decision-making.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was funded by a grant from the Changi Airport Group. Fortitude 2.1 kits were provided by the Diagnostics Development Hub (DxD Hub), A*ccelerate, Agency for Science, Technology and Research, Singapore. The study sponsor had no role in the design, implementation, analysis or write-up of the study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Director of Medical Services, Ministry of Health under the Singapore Infectious Disease Act.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All test data in the manuscript are available for sharing on request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 14, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing
Alvin Kuo Jing Teo, Yukti Choudhury, Iain Beehuat Tan, Chae Yin Cher, Shi Hao Chew, Zi Yi Wan, Lionel Tim Ee Cheng, Lynette Lin Ean Oon, Min Han Tan, Kian Sing Chan, Li Yang Hsu
medRxiv 2020.08.13.20173807; doi: https://doi.org/10.1101/2020.08.13.20173807
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Validation of Saliva and Self-Administered Nasal Swabs for COVID-19 Testing
Alvin Kuo Jing Teo, Yukti Choudhury, Iain Beehuat Tan, Chae Yin Cher, Shi Hao Chew, Zi Yi Wan, Lionel Tim Ee Cheng, Lynette Lin Ean Oon, Min Han Tan, Kian Sing Chan, Li Yang Hsu
medRxiv 2020.08.13.20173807; doi: https://doi.org/10.1101/2020.08.13.20173807

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (180)
  • Allergy and Immunology (434)
  • Anesthesia (99)
  • Cardiovascular Medicine (949)
  • Dentistry and Oral Medicine (178)
  • Dermatology (111)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (423)
  • Epidemiology (9004)
  • Forensic Medicine (4)
  • Gastroenterology (421)
  • Genetic and Genomic Medicine (1962)
  • Geriatric Medicine (191)
  • Health Economics (405)
  • Health Informatics (1330)
  • Health Policy (662)
  • Health Systems and Quality Improvement (520)
  • Hematology (212)
  • HIV/AIDS (420)
  • Infectious Diseases (except HIV/AIDS) (10826)
  • Intensive Care and Critical Care Medicine (575)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (222)
  • Neurology (1837)
  • Nursing (110)
  • Nutrition (274)
  • Obstetrics and Gynecology (356)
  • Occupational and Environmental Health (470)
  • Oncology (1003)
  • Ophthalmology (299)
  • Orthopedics (111)
  • Otolaryngology (183)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (582)
  • Pharmacology and Therapeutics (276)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1910)
  • Public and Global Health (4133)
  • Radiology and Imaging (676)
  • Rehabilitation Medicine and Physical Therapy (370)
  • Respiratory Medicine (551)
  • Rheumatology (226)
  • Sexual and Reproductive Health (191)
  • Sports Medicine (178)
  • Surgery (207)
  • Toxicology (39)
  • Transplantation (109)
  • Urology (82)